CASI Pharmaceuticals
CASI
#8753
Rank
HK$0.66 B
Marketcap
HK$42.95
Share price
-7.55%
Change (1 day)
114.28%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2022 (TTM): -HK$23.33

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$23.23. In 2021 the company made an earnings per share (EPS) of -HK$21.20 an increase over its 2020 EPS that were of -HK$34.06.

EPS history for CASI Pharmaceuticals from 1996 to 2022

Annual EPS

Year EPS Change
2022 (TTM)-HK$23.3310.03%
2021-HK$21.20-37.76%
2020-HK$34.06-8.96%
2019-HK$37.4250%
2018-HK$24.9477.78%
2017-HK$14.03-7.42%
2016-HK$15.15-11.63%
2015-HK$17.15-75.56%
2014-HK$70.16309.09%
2013-HK$17.15-72.84%
2012-HK$63.1468.75%
2011-HK$37.42-48.94%
2010-HK$73.27-19.66%
2009-HK$91.20-62.01%
2008-HK$240.09-0%
2007-HK$240.09-62.67%
2006-HK$643.09134.38%
2005-HK$274.39-13.51%
2004-HK$317.26-44.78%
2003-HK$574.50-62.36%
2002-HK$1,526-26.14%
2001-HK$2,066-20.72%
2000-HK$2,60713.43%
1999-HK$2,298150.47%
1998-HK$917.4894.55%
1997-HK$471.6027.91%
1996-HK$368.71